–308G>A and –1031T>C tumor necrosis factor gene polymorphisms in Tunisian patients with coronary artery disease
dc.contributor.author | Ghazouani, Lakhdar | |
dc.contributor.author | Khalifa, Sonia-Ben-Hadj | |
dc.contributor.author | Abboud, Nesrine | |
dc.contributor.author | Addad, Faouzi | |
dc.contributor.author | Khalfallah, Ali Ben | |
dc.contributor.author | Brahim, Nsiri | |
dc.contributor.author | Mediouni, Mounira | |
dc.contributor.author | Almawi, Wassim Y. | |
dc.contributor.author | Mahjoub, Touhami | |
dc.date.accessioned | 2017-06-17T02:43:46Z | |
dc.date.available | 2017-06-17T02:43:46Z | |
dc.date.created | 2010-07-01 | |
dc.date.issued | 2009-07-11 | |
dc.identifier.issn | 1437-4331 | |
dc.identifier.uri | http://edoc.hu-berlin.de/18452/10592 | |
dc.description.abstract | Background: Recent research has shown that inflammation plays a key role in coronary artery disease (CAD) and other manifestations of atherosclerosis. Several lines of evidence support a key role for tumor necrosis factor-α (TNF-α), a potent immunomodulator and pro-inflammatory cytokine, in the development of atherosclerosis and in complications of CAD. Methods: We investigated the possible association between CAD and the TNF gene promoter polymorphisms –308G>A and –1031T>C in a Tunisian population. We compared the distribution of these polymorphisms between 418 patients with CAD and 406 healthy controls using polymerase chain reaction restriction fragment length-polymorphism analysis. Results: The frequency of the TNF-α –308A allele in the control group was similar to that observed in CAD patients [p=0.78; odds ratio (OR)=1.15; 95% confidence interval (CI)=0.86–1.55], but higher than those described in other Europeans, such as in the French, Finnish and Spanish. Concerning the TNF-α –1031T/C polymorphism, the same distribution was observed between patients with CAD and controls (p=0.12; OR=1.27; 95% CI=0.94–1.72). In addition, the genotype and allele frequencies of control individuals were comparable to those previously reported in healthy Tunisian controls and other ethnic groups. Haplotype analysis (TNF-α –308G>A and –1031T>C) demonstrated no significant association between TNF haplotypes and CAD. Conclusions: We conclude that TNF promoter gene polymorphisms at position –308G>A and –1031T>C do not play a major role in the pathogenesis of CAD in the Tunisian population. Clin Chem Lab Med 2009;47:1247–51. | eng |
dc.language.iso | und | |
dc.publisher | Kooperation de Gruyter | |
dc.rights.uri | http://rightsstatements.org/vocab/InC/1.0/ | |
dc.title | –308G>A and –1031T>C tumor necrosis factor gene polymorphisms in Tunisian patients with coronary artery disease | |
dc.type | article | |
dc.identifier.urn | urn:nbn:de:kobv:11-100119784 | |
dc.identifier.doi | 10.1515/CCLM.2009.287 | |
dc.identifier.doi | http://dx.doi.org/10.18452/9940 | |
local.edoc.container-title | Clinical Chemistry and Laboratory Medicine | |
local.edoc.type-name | Zeitschriftenartikel | |
local.edoc.container-type | periodical | |
local.edoc.container-type-name | Zeitschrift | |
local.edoc.container-publisher-name | de Gruyter | |
local.edoc.container-volume | 47 | |
local.edoc.container-issue | 10 | |
local.edoc.container-year | 2009 | |
local.edoc.container-firstpage | 1247 | |
local.edoc.container-lastpage | 1251 | |
dc.description.version | Peer Reviewed |